Securities code: 000806 securities abbreviation: Galaxy Biomedical Investment Co.Ltd(000806) Announcement No.: 2022-012
Galaxy Biomedical Investment Co.Ltd(000806)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. hot tip
1. The shareholders’ meeting did not veto the proposal.
2. This shareholders’ meeting does not involve changing the resolutions adopted at previous shareholders’ meetings.
1、 Meetings held
Notice of meeting: Galaxy Biomedical Investment Co.Ltd(000806) (hereinafter referred to as “the company”) the notice of the first extraordinary general meeting of shareholders in 2022 was issued in the form of announcement on January 22, 2022.
Meeting time:
(1) On site meeting time: 2:00 p.m. on Friday, February 11, 2022;
(2) Online voting time: February 11, 2022. The specific time of online voting through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on February 11, 2022; The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time from 9:15 to 15:00 on February 11, 2022.
Venue of the on-site meeting: conference room of comprehensive office building of Galaxy software science and Technology Park, Beihai, Guangxi.
Convening method of the meeting: the shareholders’ meeting is held by combining on-site voting and online voting. Convener: Board of directors
Moderator: Liu Keyang, chairman of the company
The convening and convening of this general meeting of shareholders comply with the provisions of the company law of the people’s Republic of China, the rules for the general meeting of shareholders of listed companies and other relevant laws and regulations, departmental rules, normative documents and the articles of association of the company.
2、 Attendance at the meeting
1. A total of 81 shareholders and shareholder representatives attended the general meeting, representing the number of shares of the company
431456118 shares, accounting for 39.2264% of the total shares of the company. There are 80 shareholders and shareholder representatives with voting rights, holding 169652977 shares, accounting for 15.4242% of the total voting shares of the company, including 2 Shareholders and shareholder representatives attending the meeting, holding 16700 shares, accounting for 0.0015% of the total voting shares of the company, and 78 shareholders voting through the Internet, holding 169636277 shares, Accounting for 15.4227% of the total voting shares of the company.
2. Attendance of minority shareholders: a total of 79 shareholders voted on site and online, representing 27552977 shares, accounting for 2.5050% of the total voting shares of the company. Among them, there are 2 shareholders who vote on site, representing 16700 shares, accounting for 0.0015% of the total voting shares of the company; A total of 77 shareholders voted online, representing 27536277 shares, accounting for 2.5035% of the total voting shares of the company.
3. Some directors, supervisors and senior managers of the company attended or attended the meeting through on-site or video. The witness lawyer of Beijing Jincheng Tongda (Shanghai) law firm witnessed the shareholders’ meeting and issued legal opinions.
3、 Deliberation and voting of proposals
The general meeting of shareholders adopted a combination of on-site open voting and online voting to vote on the proposals under consideration. The votes were monitored and counted in accordance with the regulations, and the voting results were announced on the spot. The voting results of the meeting are as follows:
Deliberating the proposal on signing the agreement on debt repayment
This proposal involves related party transactions. The number of shares held by the related shareholder Galaxy Tiancheng Group Co., Ltd. is 261803141 shares, avoiding voting.
Voting: 167745455 shares were approved, accounting for 98.8756% of the total voting shares held by shareholders attending the meeting; Against 1907522 shares, accounting for 1.1244% of the total voting shares held by shareholders attending the meeting; Abstained 0 shares, accounting for 0.0000% of the total voting shares held by shareholders attending the meeting.
Among them, the voting of minority shareholders was 25645455 shares, accounting for 93.0769% of the total voting shares held by minority investors attending the meeting; Against 1907522 shares, accounting for 6.9231% of the total voting shares held by small and medium-sized investors attending the meeting; Abstained 0 shares, accounting for 0.0000% of the total voting shares held by shareholders attending the meeting.
Voting result: adopted.
4、 Legal opinions issued by lawyers
Sun Yiwen and Hong Wei, two witness lawyers of Beijing Jinchengtongda (Shanghai) law firm, issued legal opinions on the meeting witness for the general meeting of shareholders. They believed that the convening and convening procedures of the general meeting of shareholders, the qualifications of participants and conveners, the voting procedures and voting results of the meeting were in line with the provisions of relevant laws and regulations, normative documents and the articles of association, The voting result is legal and valid.
5、 Documents for future reference
1. Resolution of the company’s first extraordinary general meeting in 2022;
2. Legal opinion issued by Beijing Jinchengtongda (Shanghai) law firm.
It is hereby announced.
Galaxy Biomedical Investment Co.Ltd(000806) board of directors
February 11, 2002
